Intermittent leukapheresis: An adjunct to low-dose chemotherapy for Sezary syndrome

M. T. McEvoy, B. D. Zelickson, A. A. Pineda, R. K. Winkelmann

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Eleven patients with Sezary syndrome were treated with intermittent leukapheresis in addition to low-dose chlorambucil and prednisone. The results were as good as or better than those with chemotherapy alone. We believe the combined program with continuous leukapheresis to be optimal therapy but note that intermittent treatments offers some benefit for patients.

Original languageEnglish (US)
Pages (from-to)73-76
Number of pages4
JournalActa Dermato-Venereologica
Volume69
Issue number1
StatePublished - Jan 1 1989
Externally publishedYes

Fingerprint

Dive into the research topics of 'Intermittent leukapheresis: An adjunct to low-dose chemotherapy for Sezary syndrome'. Together they form a unique fingerprint.

Cite this